David Lee Johnson
Chief Operating Officer · Vera Therapeutics, Inc.
- 2026
- Feb 26, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Lee Johnson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marshall Fordyce - $7.10M in VERA purchases and sales in the last 12 months
- William D. Turner - $1.45M in VERA purchases and sales in the last 12 months
- Joseph R. Young - $567K in VERA purchases and sales in the last 12 months
- Sean Grant - $208K in VERA purchases and sales in the last 12 months
- Jason S. Carter - $107K in VERA purchases and sales in the last 12 months
- Robert Brenner - $90K in VERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Lee Johnson?
David Lee Johnson is a corporate insider, tracked as Chief Operating Officer of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David Lee Johnson last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 3 filings going back to 2026.
Has David Lee Johnson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($108K) across all tracked filings.
